welcome to
the lab.
welcome to
the lab.
Inside each daily dosage, you can expect:
50 billion colony-forming units (CFU); one of the highest counts on the market.
Our dual layered capsule ensures the bacteria withstand the harsh conditions of your GI tract and reach the gut alive.
11 clinically trialled bacterial strains spanning over 8 different species.
One capsule - just once a day, every day. No gimmicks, no refrigeration, no blending.
Our capsule takes intricate health science and transforms it into one simple daily ritual, making optimal gut health an accessible goal for everyone.
Our capsule takes intricate health science and transforms it into one simple daily ritual, making optimal gut health an accessible goal for everyone.
Epetōme’s synbiotic dual cap includes state-of-the-art encapsulation - technology proven to be more effective than standard capsules at reaching the gut alive.
The transparent outer shell is designed to break down in your stomach, releasing fructooligosaccharides (FOS) fibre, which act as food for the live bacteria.
The inner capsule contains 50 billion live bacteria. The outer shell protects this as it moves through the acidic conditions of the stomach, where unprotected bacteria are often destroyed.
Emily English is a BSc qualified nutritionist. During her time running a London clinic, she noticed a significant increase in clients with digestive health issues, sparking the inspiration behind Epetōme’s unique formulation.
spanning 8 different species.
Our synbiotic dual cap is a careful blend of science and nature.
Partnering with leading scientists and researchers, Emily developed a formulation designed with modern lives in mind. The result? 11 bacterial strains spanning 7 species.
450+ studies have been conducted on our strains over a 46 year period, exploring hypotheses across digestion, skin, cognition, immunity and hormones.
strain taxonomy with transparency.
Many bacterial supplements only disclose the genus and species in their formulation. But the strain code matters.
NCFM
This bacteria is here to support digestion, helping with bloating and stomach pain. It also supports immune health and has been studied in cognition and skin health.
LA14
This bacteria is here to support balanced immune function and healthy immune responses.
LP-115
This bacteria is here to support the immune system and help maintain gut comfort during intestinal disorders.
GG
This bacteria is here to support digestive balance during diarrhoea and inflammatory bowel conditions. It has also been studied in atopic dermatitis.
HN001
This bacteria is here to enhance immune function and support natural immune responses. It has also shown potential in eczema.
HN019
This bacteria is here to relieve constipation and support regular bowel movements.
BL04
This bacteria is here to support the gut barrier, regulate immune defence and reduce the incidence of diarrhoea. It is also linked to the gut brain axis.
BB18
This bacteria is here to support the development and maintenance of the gut immune system and increase resistance to infections.
BB06
This bacteria is here to support the gut-brain and gut-skin axes.
BL05
This bacteria is here to support a balanced gut microbiome and improve bloating, constipation, diarrhoea and abdominal discomfort.
LPC-37
This bacteria is here to support digestive health and help manage the body’s response to stress.
our research findings.
SHIME® trials.
SHIME testing, or Simulator of the Human Intestinal Microbial Ecosystem, is a sophisticated in vitro technology that simulates the human gastrointestinal tract.
You may not have heard of SHIME® from many other supplement brands, as the rigorous process can quickly expose flaws.
For Epetōme, utilising SHIME® testing to validate the efficacy of the synbiotic dual cap underscores a commitment to scientific excellence and consumer benefit.
In collaboration with market leading research firm ProDigest, we conducted an independent SHIME® trial to test how well the live bacteria inside our synbiotic dual cap survive the journey to the gut, compared to the bacteria in the leading liquid and powder formulas.
The synbiotic dual cap had 12x higher survivability rates than the leading liquid, and 23x higher than the leading powder.
Epetōme's synbiotic dual cap delivered 38.5% to the distal ileum (the last part of your small intestine) and colon, unlike the competitor products whose ‘naked’ formulations showed significant drops in viable cell counts.
ingredient-led research.
